Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 6:8:6.
doi: 10.1186/s13040-015-0039-3. eCollection 2015.

An investigation of gene-gene interactions in dose-response studies with Bayesian nonparametrics

Affiliations

An investigation of gene-gene interactions in dose-response studies with Bayesian nonparametrics

Andrew L Beam et al. BioData Min. .

Abstract

Background: Best practice for statistical methodology in cell-based dose-response studies has yet to be established. We examine the ability of MANOVA to detect trait-associated genetic loci in the presence of gene-gene interactions. We present a novel Bayesian nonparametric method designed to detect such interactions.

Results: MANOVA and the Bayesian nonparametric approach show good ability to detect trait-associated genetic variants under various possible genetic models. It is shown through several sets of analyses that this may be due to marginal effects being present, even if the underlying genetic model does not explicitly contain them.

Conclusions: Understanding how genetic interactions affect drug response continues to be a critical goal. MANOVA and the novel Bayesian framework present a trade-off between computational complexity and model flexibility.

Keywords: Bayesian nonparametric; Dose-response; Epistasis; Machine learning; Neural network.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graphical depiction of a neural network with several output units. The blue nodes on the bottom represent SNPs in MAF coding, the orange nodes represent the hidden unit functions in Equation (3), and the red nodes at the top represent the estimated response for each of the concentrations measured. This architecture allows the network to model the response at each concentration as a nonlinear combination of the input SNPs.
Figure 2
Figure 2
Overview of the Bayesian neural network method for dose-response studies. First the network architecture is established and transferred along with the data to GPU memory. The HMC simulation is performed on the GPU and the samples are then transferred back to main memory. The posterior for each SNP’s ARD parameter is compared to the null distribution. Bayesian posterior probabilities are computed to assess how likely each SNP is to be involved in determing drug-response. In the right panel SNP 1 shows little evidence of being involved with this trait while SNP P has strong evidence of playing a role.
Figure 3
Figure 3
Power results for the additive model. The power for the Bayesian neural network (BNN) model is shown in blue while MANOVA is shown in orange. Solid lines indicate the power to detect both loci, while the dashed lines indicate power to detect at least one of the causal loci.
Figure 4
Figure 4
Power results for the additive model with interactions. The power for the Bayesian neural network (BNN) model is shown in blue while MANOVA is shown in orange. Solid lines indicate the power to detect both loci, while the dashed lines indicate power to detect at least one of the causal loci.
Figure 5
Figure 5
Power results for the purely interactive mode. The power for the Bayesian neural network (BNN) model is shown in blue while MANOVA is shown in orange. Solid lines indicate the power to detect both loci, while the dashed lines indicate power to detect at least one of the causal loci.

Similar articles

References

    1. Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, et al. Pharmacogenomic discovery using cell-based models. Pharmacol Rev. 2009;61(4):413–29. doi: 10.1124/pr.109.001461. - DOI - PMC - PubMed
    1. Wheeler HE, Dolan ME. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics. 2012;13(1):55–70. doi: 10.2217/pgs.11.121. - DOI - PMC - PubMed
    1. Brown CC, Havener TM, Medina MW, Jack JR, Krauss RM, McLeod HL, et al. Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics. 2014;15(2):137–46. doi: 10.2217/pgs.13.213. - DOI - PMC - PubMed
    1. Brown CC, Havener TM, Medina MW, Auman JT, Mangravite LM, Krauss RM, et al. A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines reveals a clinically relevant association with mgmt. Pharmacogenetics Genomics. 2012;22(11):796. doi: 10.1097/FPC.0b013e3283589c50. - DOI - PMC - PubMed
    1. Brown C, Havener TM, Everitt L, McLeod H, Motsinger-Reif AA. A comparison of association methods for cytotoxicity mapping in pharmacogenomics. Front Genet. 2011;2:86. doi: 10.3389/fgene.2011.00086. - DOI - PMC - PubMed

LinkOut - more resources